Bio-Rad Laboratories, Inc. (BIO) stock
BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3069% below fair value
$370.48−15.52 (-4.02%)
Close on Nov 12, 2026Market cap $10.00BP/E 9.9Yield –
Bio-Rad Laboratories statistics
97 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.44
- 4.85
- P/OCF Ratio
- 21.37
- 22.12
Enterprise valuationIndustry
- EV / Sales
- 3.53
- 2.70
- EV / FCF
- 27.78
- 27.78
Share statisticsIndustry
- Shares Change (YoY)
- -2.15%
- 3.22%
- Float
- 12M
- 37M
- Shares Held by Insiders
- 54.5%
- 10.5%
- Shares Held by Institutions
- 83.2%
- 60.2%
Short sellingIndustry
- Short Interest
- 1M
- –
- Short Interest Change
- 5.41%
- -2.57%
- Days to Cover
- 5.07
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $396.23
- –
- 52-Week Low
- $236.73
- –
- 20-Day Moving Average
- $372.65
- –
- 50-Day Moving Average
- $373.38
- –
- 200-Day Moving Average
- $316.63
- –
- Average True Range (14)
- $13.33
- –
- Price Change (1 Week)
- 0.40%
- 1.87%
- Price Change (1 Month)
- 2.22%
- -0.57%
- Price Change (3 Months)
- 3.99%
- -7.91%
- Price Change (6 Months)
- 50.4%
- -0.90%
- Price Change (YTD)
- 22.3%
- -0.87%
- Price Change (1 Year)
- 18.2%
- -1.18%
- Price Change (3 Years)
- 22.0%
- 6.56%
- Price Change (5 Years)
- -51.0%
- -49.8%
- Price Change (10 Years)
- 122.2%
- 72.9%
- Average Volume (10 Days)
- 275,103
- –
- Average Volume (20 Days)
- 253,904
- –
- Average Volume (90 Days)
- 267,910
- –
- Relative Volume
- 0.68
- 0.82
- Relative Strength Index (14)
- 47.7
- 47.7
- Volatility (1 Year)
- 36.5%
- 64.2%
- Beta (5 Years)
- 1.02
- 1.04
MarginsIndustry
- Pretax Margin
- 50.9%
- -2.55%
- EBITDA Margin
- -2.39%
- -2.82%
- FCF Margin
- 12.7%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- 14.3%
- -17.1%
- Return on Assets (ROA)
- 9.99%
- -12.2%
- Return on Invested Capital (ROIC)
- -0.72%
- -3.22%
- Return on Capital Employed (ROCE)
- -0.63%
- -8.13%
Financial positionIndustry
- Current Ratio
- 3.18
- 2.45
- Quick Ratio
- 2.15
- 1.53
- Debt / Equity
- 0.11
- 0.42
- Debt / FCF
- 2.44
- 3.62
- Interest Coverage
- -1.27
- -1.68
GrowthIndustry
- Revenue Growth (YoY)
- 1.38%
- 9.24%
- FCF Growth (YoY)
- -2.29%
- 7.64%
- Revenue Growth (3Y CAGR)
- -2.68%
- 7.08%
- Revenue Growth (5Y CAGR)
- 0.29%
- 11.8%
- EPS Growth (5Y CAGR)
- -26.1%
- 7.64%
EfficiencyIndustry
- Asset Turnover
- 0.25
- 0.59
- Inventory Turnover
- 1.61
- 2.20
- Revenue Per Employee
- $348.01K
- $330.60K
- Profits Per Employee
- $137.30K
- -$41.39K
- Employee Count
- 7,450
- 186
- WACC
- 9.68%
- 9.79%
Income statement (TTM)Industry
- Pretax Income
- $1.32B
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- $861.20M
- $3.73M
- Net Cash Per Share
- $32.21
- $0.24
- Equity (Book Value)
- $7.60B
- $63.44M
- Book Value Per Share
- $284.35
- $3.26
- Tangible Book Value
- $6.93B
- $11.04M
- Working Capital
- $2.11B
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$139.00M
- -$3.69M
- FCF Per Share
- $12.31
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- 10.2%
- -4.70%
- FCF Yield
- 3.29%
- 0.24%
- Buyback Yield
- 0.79%
- 0.79%
- Shareholder Yield
- 0.79%
- 1.05%
Taxes and interestIndustry
- Interest Expense
- $48.80M
- $5.33M
- Income Tax
- $297.30M
- $1.63M
- Effective Tax Rate
- 22.5%
- 18.3%
Scores and fair valueIndustry
- Graham Number
- $492.88
- $38.11
- Graham Upside
- 31.7%
- -56.6%
- Altman Z-Score
- 3.44
- 2.44
- Piotroski F-Score
- 6
- 5
- Beneish M-Score
- -2.29
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIO | S&P 500 | Difference | BIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +1.7% | -2.7% | +4.4 pts | ||
| 3 months | +2.3% | -1.7% | +4.1 pts | ||
| Year to date | +22.3% | +11.9% | +10.4 pts | ||
| 1 year | +13.2% | +12.0% | +1.2 pts | ||
| 3 years | +21.9% | +78.2% | −56.3 pts | +6.8% | +21.2% |
| 5 years | -51.0% | +73.2% | −124.3 pts | -13.3% | +11.6% |
| 10 years | +122.2% | +309.6% | −187.4 pts | +8.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M BIO shares were sold short on Oct 30, 2026, up 5.4% from the previous report. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 65.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,156,915 | +5.4% | 228,195 | 5.1 |
| Oct 15, 2026 | 1,097,562 | -7.2% | 226,555 | 4.8 |
| Sep 30, 2026 | 1,182,765 | +18.4% | 276,887 | 4.3 |
| Sep 15, 2026 | 998,654 | -11.6% | 260,959 | 3.8 |
| Aug 31, 2026 | 1,130,298 | -14.9% | 266,609 | 4.2 |
| Aug 14, 2026 | 1,327,739 | -6.0% | 275,201 | 4.8 |
| Jul 31, 2026 | 1,412,268 | -9.4% | 329,435 | 4.3 |
| Jul 15, 2026 | 1,559,452 | +2.8% | 261,563 | 6.0 |
| Jun 30, 2026 | 1,517,121 | -0.3% | 372,136 | 4.1 |
| Jun 15, 2026 | 1,521,346 | +1.0% | 347,408 | 4.4 |
| May 29, 2026 | 1,506,093 | +12.3% | 577,789 | 2.6 |
| May 15, 2026 | 1,340,805 | +22.8% | 459,353 | 2.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?